| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
146,000,000 |
| Market
Cap: |
16.10(B) |
| Last
Volume: |
3,139,512 |
Avg
Vol: |
1,357,255 |
| 52
Week Range: |
$92.79 - $202.15 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 11.4 |
| Insider 3/6 Months : 12 |
|
| Guru Rank Number : 691 |
| Guru Rank Value : 2.3 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
7,330 |
7,330 |
7,330 |
| Total Buy Value |
$0 |
$991,672 |
$991,672 |
$991,672 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
1,315 |
22,740 |
| Total Sell Value |
$0 |
$0 |
$214,105 |
$4,648,975 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
3 |
17 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dadswell Charles |
Sr VP & General Counsel |
• • – |
2018-03-05 |
4 |
AS |
$227.17 |
$32,940 |
D/D |
(145) |
7,991 |
|
- |
|
| Ostadan Omead |
EVP Ops, Products, Strategy |
• • – |
2018-03-02 |
4 |
AS |
$222.29 |
$295,916 |
D/D |
(1,329) |
28,467 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2018-03-01 |
4 |
AS |
$224.28 |
$681,028 |
D/D |
(3,000) |
16,868 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2018-03-01 |
4 |
OE |
$44.51 |
$133,530 |
D/D |
3,000 |
19,868 |
|
- |
|
| Epstein Robert S |
Director |
• • – |
2018-02-28 |
4 |
AS |
$231.25 |
$57,813 |
D/D |
(250) |
7,088 |
|
- |
|
| Van Oene Mark |
SVP Chief Commercial Officer |
• • – |
2018-02-16 |
4 |
AS |
$228.85 |
$322,221 |
D/D |
(1,408) |
13,617 |
|
- |
|
| Van Oene Mark |
SVP Chief Commercial Officer |
• • – |
2018-02-15 |
4 |
D |
$229.13 |
$168,411 |
D/D |
(735) |
15,025 |
|
- |
|
| Van Oene Mark |
SVP Chief Commercial Officer |
• • – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,124 |
15,760 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2018-02-15 |
4 |
D |
$229.13 |
$2,951,653 |
D/D |
(12,882) |
400,824 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,542 |
413,706 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2018-02-15 |
4 |
D |
$229.13 |
$1,012,525 |
D/D |
(4,419) |
88,571 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,238 |
92,990 |
|
- |
|
| Stapley Marc |
EVP Strategy & Corp Developmt |
• • – |
2018-02-15 |
4 |
D |
$229.13 |
$586,344 |
D/D |
(2,559) |
29,871 |
|
- |
|
| Stapley Marc |
EVP Strategy & Corp Developmt |
• • – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,257 |
32,430 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-02-15 |
4 |
D |
$229.13 |
$409,914 |
D/D |
(1,789) |
70,996 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,740 |
72,785 |
|
- |
|
| Dadswell Charles |
Sr VP & General Counsel |
• • – |
2018-02-15 |
4 |
D |
$229.13 |
$302,222 |
D/D |
(1,319) |
8,136 |
|
- |
|
| Dadswell Charles |
Sr VP & General Counsel |
• • – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,792 |
9,455 |
|
- |
|
| Ostadan Omead |
EVP Ops, Products, Strategy |
• • – |
2018-02-15 |
4 |
D |
$299.13 |
$765,474 |
D/D |
(2,559) |
29,796 |
|
- |
|
| Ostadan Omead |
EVP Ops, Products, Strategy |
• • – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,257 |
32,355 |
|
- |
|
| Stapley Marc |
EVP Strategy & Corp Developmt |
• • – |
2018-02-06 |
4 |
AS |
$207.95 |
$433,741 |
D/D |
(2,000) |
26,052 |
|
- |
|
| Dadswell Charles |
Sr VP & General Counsel |
• • – |
2018-02-05 |
4 |
AS |
$221.45 |
$356,535 |
D/D |
(1,610) |
5,581 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2018-02-01 |
4 |
AS |
$230.06 |
$692,448 |
D/D |
(3,000) |
16,868 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2018-02-01 |
4 |
OE |
$44.51 |
$133,530 |
D/D |
3,000 |
19,868 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2018-01-30 |
4 |
D |
$241.18 |
$201,868 |
D/D |
(837) |
437,062 |
|
- |
|
1655 Records found
|
|
Page 28 of 67 |
|
|
1.67 (1.54%) 
